ArticleTargeted oncology2013
Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation.
Filip Janku et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleTargeted oncology2013
Filip Janku et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.